Respiratory syncytial virus (RSV) is a leading cause of illness and hospitalization among very young children. This is an experimental vaccine to protect against RSV elicited high levels of RSV-specific antibodies when tested in animals, according to a report in the journal emScience/em. Early-stage human clinical trials of the candidate vaccine are planned. Scientists from the Vaccine Research Center (VRC), National Institute of Allergy and Infectious ...
Read More
No comments:
Post a Comment